期刊文献+

重组葡激酶脂质体的制备、活性及包封率测定方法的研究

Study on preparation of recombinant staphylokinase liposome and determination of its activity and entrapment efficiency
下载PDF
导出
摘要 目的:研究重组葡激酶脂质体的制备、活性及其包封率的测定方法,为重组葡激酶脂质体的研究开发提供实验数据。方法:薄膜分散法制备重组葡激酶脂质体并用溶圈法测定其活性,分别采用超速离心和直接点样2种方法测定重组葡激酶脂质体的包封率。结果:溶圈法测定重组葡激酶活性的板内精密度的 RSD 为8.4%(n=5),板间精密度的 RSD 为12.4%(n=5)。直接点样法测定所制备的3批重组葡激酶脂质体包封率分别为54.36%,51.67%,54.67%;离心法测定所制备的3批重组葡激酶脂质体包封率分别为71.75%,67.43%,68.46%。所制备的重组葡激酶脂质体表面药物吸附量为15.65%。结论:溶圈法可用于重组葡激酶脂质体活性的测定;离心法测定的重组葡激酶脂质体包封率包括脂质体表面吸附药量;离心法与直接点样法测定包封率的差值为脂质体表面吸附药物量。 Objective: To prepare recombinant staphylokinase ( r - Sak) liposome and develop a methods to determinate its activity and entrapment efficiency for providing the experimental basis in the study and development of r- Sak liposome preparation. Methods: The liposomes containing r - Sak were prepared by film dispersion method and their fibrinolytic activities were determined by "lytic circle" method. Entrapment efficiency was respectively measured by ultracentrifugation spotting method and directly spotting method. Results: The RSDs ( n = 5 ) of intra - plates and inter - plates for assay of fibrinolytic activity with lytic circle method were 8.4% and 12. 4% respectively. The entrapment efficiencies of three batches of r - Sak liposomes were 54. 36% ,51.67% and 54. 67% respectively using directly spotting method and 71.75% ,67.43% and 68.46% respectively using ultracentrifugation spotting assay method. The adsorption percentage of r -Sak on the surface of liposomes was 15.65%. Conclusions:" Lytic circle" method can be used to assay the activities of r - Sak liposomes, and the entrapment efficiencies of r - Sak in liposomes determined by using uhracentrifugation spotting assay contained the amounts of r - Sak adsorbed on surface of liposome. The difference of two entrapment efficiencies obtained respectively from using ultracentrifugation spotting assay and directly spotting method was the amounts of r - Sak adsorbed on surface of liposome.
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第5期703-707,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 重组葡激酶 脂质体 包封率 溶圈法 recombinant staphylokinase ( r - Sak) liposome entrapment efficiency lytic circle
  • 相关文献

参考文献12

  • 1Lack CH. Staphylokinase: an activator of plasma protease. Nature, 1948,161:559
  • 2Collen D, Schlott B, Engelborghs Y, et al. On the mechanism of the activation of human plasminogen by recombinant staphylokinase. J Biol Chem, 1993,268 ( 11 ) : 8284
  • 3Sako T, Sawaki T, Ito S, et al. Cloning and expression of staphylokinase gene of Staphylococcus aureus in Escherichia coli. Mol Gen Genet,1983 ,190 :271
  • 4桂向东,吴清发,范清林,傅永标,宋礼华.葡萄球菌激酶(Sak)的基因克隆和高效表达工程菌的构建[J].生物学杂志,1998,15(4):12-14. 被引量:4
  • 5汤其群,张小璇,于敏,宋后燕.重组葡激酶(r-Sak)的分离、纯化和结晶[J].药物生物技术,1997,4(1):1-4. 被引量:15
  • 6杨伟,李伯刚,周正质,赵德英,邱芬,张罗红.重组葡激酶(r-Sak)在家兔体内的药代动力学研究[J].天然产物研究与开发,1997,9(2):71-75. 被引量:2
  • 7Vanderschueren SM, Stassen JM, Collen D. On the immunogenicity of recombinant staphylokinase in patients and in animal models. Thromb Haemost, 1994,72 ( 2 ) : 297
  • 8Derlerk PJ, Vandersehueren S, Billiet J, et al. Prevalence and induction of cireulating antibodies against recombinant staphylokinase. Thromb Haemost, 1994,71 ( 1 ) : 129
  • 9叶志伟,胡巧红,梁文权.粉末床研磨法制备干扰素-α脂质体[J].浙江大学学报(医学版),2002,31(6):433-436. 被引量:8
  • 10WANG Jun—zhi(王军志).Study and Quality Control of Biotechniqual Drugs(生物技术药物研究开发和质量控制).Beijing(北京):Science press(科学出版社),2002.522

二级参考文献13

  • 1王鹏,王玉珠,沈建民.均匀设计及其在药学中的应用[J].沈阳药学院学报,1989,6(4):297-305. 被引量:74
  • 2[1]Lijnen HR, Stassen JM, Vanlintbout I, et al. Comparative fibrinoly tic properties of stsphylokinase and streptokinase in animal model of venous thrombosis. Thrornb Haemost, 1991,66(4) :468
  • 3[2]Collen D,De Cock F,Vanlinthout I, et al. Comparative thrombolytic and immunogenic properties of staphylokinase and streptokinase. Fibrinolysis, 1992,6: 232
  • 4[3]Lijinen HR,Beelen V,Declerck PJ, et al. Bioinantanoassay for staphyloki nase in blood. Thromb Haenmost ,1993,70(3) :491
  • 5[4]Collen D, Van de Werf F. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. Circulation, 1993,87 (6): 1850
  • 6[5]Stassen JM, Nystrom A, Hoylaerts M, et al. Antithrombotic effects of thrombolytic agents in a platelet-rich ferrnral vein thrombosis model in the hamster. Circulation, 1995,91 (5): 1330
  • 7REN Jin-yu,CHEN Yi,WU Bin, et al(任进余,陈义,吴斌,等). Study of the targeting therapy on virus hepa-titis: preparation and clinical observation of the liposomal drugs for anti-HBV [J]. Chinese Journal Integrate Tradition and West Hepatology(中西医结合肝病杂志),1997,7(1):1-3.(in Chinese)
  • 8WANG Li(王黎).Study of drug delivery system for targeting therapy on hepatitis [J].Foreign Medical Sciences Sections on Pharmacy(国外医学*药学分册), 2001,21(6):379-381.(in Chinese)
  • 9Crommelin D J A. Influence of lipid composition and ionic strengthen thephysical stability of liposome[J]. J. Pharm. Sci, 1984,73(11):1559-1663.
  • 10Maria B, Richard M E. Effect of sugar alcohol and di-saccharide in inducing the hexagonal base and altering membrane properties: implications for diabetes mellitus. Biochim Biophys Acta, 1988,943(3):485-492.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部